Editor-in-Chief: Benjamin Bonavida
Aims and Scope
The primary objective of the Critical Reviews in Oncogenesis (CRO) is the update and dissemination of scientific and clinical knowledge pertaining to the underlying molecular bases of oncogenesis by emphasizing both the journal's originality and scientific merit. CRO is dedicated to publishing timely critical reviews on topics of current interests with emphases on basic, molecular and translational applications in the field of oncogenesis. Further emphasis is focused on the roles of oncogenesis in the development of cancer and malignancies and cancer stem cells and their oncogenic potential. Reviews also consider the role of oncogenes as diagnostic biomarkers and therapeutic targets. Hence, CRO publishes special thematic issues on the above described topics and emphasizes multidisciplinary approaches.
In contrast to reviews in several other publications, CRO is highly focused on a specific and a unique thematic approach for each issue, edited by invited Editor(s), with contributions by various experts. This multidisciplinary approach for a coherent theme in Oncogenesis distinguishes CRO from many other review journal in which individual reviews that are not always interrelated, are often published. The unique Aims and Scope of CRO will lead to a wide readership and will be used as an essential reference for research scientists, clinicians, students, health professionals, and biopharmaceutical industries.
The paramount questions we are now facing are the cellular and molecular mechanisms responsible for the induction of such a protective antiviral immunity, with a particular emphasis on the interactions between immune complexes formed during the immunotherapy and the various immune cell types. This is addressed in vaccination experiments conducted in different genetically engineered mice lines, as well as in various ex vivo assays involving immune cells of various types. We are also currently extending our observations to the treatment of HIV infections.